Chargement en cours...
Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment
Background: The glycoprotein (GP) IIb/IIIa inhibitors are potent antagonists of platelet aggregation that are approved to prevent thrombotic complications of percutaneous coronary intervention and for medical treatment of patients with acute coronary ischaemic syndromes. From safety data obtained fr...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Copyright 2003 by Heart
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1767648/ https://ncbi.nlm.nih.gov/pubmed/12695459 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|